I型干扰素对工程化儿童骨骼肌的作用:一种有前景的幼年皮肌炎模型
研究从3名健康儿童供体分离原代成肌细胞构建肌束,暴露于0、5、10或20 ng/ml IFN-α或IFN-β 7天后电刺激测试并免疫组化分析。IFN-β而非IFN-α与收缩强直力下降和抽搐动力学减慢相关,托法替布和巴瑞替尼可逆转这些效应。I型干扰素矛盾性降低肌束疲劳且JAKi未逆转,MHC I上调经JAKi后正常化,而Mi-2、黑色素细胞分化相关蛋白5和GRP78表达呈供体特异性变化。
要点
- IFN-β而非IFN-α与儿童肌束收缩强直力下降及抽搐动力学减慢相关,托法替布和巴瑞替尼可逆转。
- I型干扰素降低肌束疲劳且JAKi未逆转,MHC I上调经JAKi后正常化。
- Mi-2、黑色素细胞分化相关蛋白5和GRP78表达在I型干扰素暴露后呈供体特异性变化。
核心结论
- IFN-α和IFN-β对儿童骨骼肌有不同效应,JAKi治疗可部分逆转这些效应。
- 这是首个展示三维人骨骼肌模型有效用于研究JDM发病机制和测试新疗法的研究。
研究设计与样本
- 从3名健康儿童供体分离原代成肌细胞构建模拟功能性骨骼肌结构和生理功能的肌束。
- 肌束暴露于0、5、10或20 ng/ml IFN-α或IFN-β 7天后电刺激功能测试并免疫组化分析。
- IFN-β暴露肌束另用JAKi托法替布和巴瑞替尼处理并分析收缩力和免疫组化。
主要发现
- IFN-β而非IFN-α与收缩强直力下降和抽搐动力学减慢相关,托法替布和巴瑞替尼可逆转这些效应。
- I型干扰素矛盾性降低肌束疲劳,JAKi处理后未逆转。
- I型干扰素与MHC I上调相关,JAKi处理后正常化。
- I型干扰素暴露后Mi-2、黑色素细胞分化相关蛋白5和GRP78表达呈可变且供体特异性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate pathogenic mechanisms underlying JDM, we defined the effect of type I IFN, IFN-α and IFN-β, on pediatric skeletal muscle function and expression of myositis-related proteins using an in vitro engineered human skeletal muscle model (myobundle). METHODS: Primary myoblasts were isolated from three healthy pediatric donors and used to create myobundles that mimic functioning skeletal muscle in structural architecture and physiologic function. Myobundles were exposed to 0, 5, 10 or 20 ng/ml IFN-α or IFN-β for 7 days and then functionally tested under electrical stimulation and analyzed immunohistochemically for structural and myositis-related proteins. Additionally, IFN-β-exposed myobundles were treated with Janus kinase inhibitors (JAKis) tofacitinib and baricitinib. These myobundles were also analyzed for contractile force and immunohistochemistry. RESULTS: IFN-β, but not IFN-α, was associated with decreased contractile tetanus force and slowed twitch kinetics. These effects were reversed by tofacitinib and baricitinib. Type I IFN paradoxically reduced myobundle fatigue, which did not reverse after JAKi. Additionally, type I IFN correlated with MHC I upregulation, which normalized after JAKi treatment, but expression of myositis-specific autoantigens Mi-2, melanocyte differentiation-associated protein 5 and the endoplasmic reticulum stress marker GRP78 were variable and donor specific after type I IFN exposure. CONCLUSION: IFN-α and IFN-β have distinct effects on pediatric skeletal muscle and these effects can partially be reversed by JAKi treatment. This is the first study illustrating effective use of a three-dimensional human skeletal muscle model to investigate JDM pathogenesis and test novel therapeutics.
引用
- Covert LT, Patel H, Osman A, et al. Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis. Rheumatology (Oxford). 2024. PMID: 37094222. doi:10.1093/rheumatology/kead186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。